Inside Views: WHO’s Access Roadmap And The Art Of Accommodation Of Pharma Interest


The Roadmap to access to medicines, vaccines and other health products (Roadmap) to be discussed at this week’s 144th session of WHO’s Executive Board accommodates vital interest of pharmaceutical TNCs on critical issues such as the approach to access, technical assistance on the use of TRIPS flexibilities and access to biosimilars.

Adoption of the Roadmap in its current form very well accommodates the interest of the Pharmaceutical TNCs and therefore one need not expect any proactive steps by WHO towards promoting access after the adoption of the Roadmap.
Fonte:http://www.ip-watch.org/2019/01/26/whos-access-roadmap-art-accommodation-pharma-interest/
Author: Intellectual Property Watch

WordPress Video Lightbox
Cerca